Freek Beekman (R3) obtained Frost & Sullivan Award
11 October 2010 by M&C Applied Sciences/R3Prof. Freek Beekman from R3 and his company MILabs was presented with the Frost & Sullivan New Product Innovation Award for Diagnostics and Medical Imaging for the invention of VECTor, the first instrument that can perform SPECT and PET simultaneously and with an unsurpassed resolution.
Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company''s Growth Partnership Service provides the CEO and the CEO''s Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages almost 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com
Milabs
Milabs is a biotechnology company located in the Netherlands (www.milabs.com). It develops and markets premium imaging systems for preclinical biological and pharmaceutical research. Milabs was founded by Professor Freek Beekman from TU Delft who designed the first U-SPECT system, a SPECT system with ultra-high resolution. Since then there have been several new developments that dramatically improved performance and user friendliness. The company’s first commercial breakthrough came in 2007, and since then it is showing very rapid growth. Recently Milabs introduced VECTor and VECtor/CT, that image PET and SPECT tracers simultaneously at an unprecedented resolution.
Go to the spin-off for more information.
